Literature DB >> 10552234

Episodic vertigo related to migraine (90 cases): vestibular migraine?

M Dieterich1, T Brandt.   

Abstract

A retrospective study was conducted on 90 patients with episodic vertigo that could be related to migraine as the most probable pathomechanism. Since the majority of the patients did not fulfill the criteria of the International Headache Society (IHS) for basilar migraine, the diagnosis was substantiated by disease course, medical efficacy in treating (ergotamines) and preventing (metoprolol, flunarizine) attacks, ocular motor abnormalities in the symptom-free interval, and careful exclusion of the most relevant differential diagnoses, such as transient ischemic attacks, Menière's disease, and vestibular paroxysmia. The following clinical features were elaborated. The initial manifestation could occur at any time throughout life, with a peak in the fourth decade in men and a "plateau" between the third and fifth decades in women. The duration of rotational (78%) and/or to-and-fro vertigo (38%) could last from a few seconds to several hours or, less frequently, even days; duration of a few minutes or of several hours was most frequent. Monosymptomatic audiovestibular attacks (78%) occurred as vertigo associated with auditory symptoms in only 16%. Vertigo was not associated with headache in 32% of the patients. In the symptom-free interval 66% of the patients showed mild central ocular motor signs such as vertical (48%) and/or horizontal (22%) saccadic pursuit, gaze-evoked nystagmus (27%), moderate positional nystagmus (11%), and spontaneous nystagmus (11%). Combinations with other forms of migraine were found in 52%. Thus, migraine is a relevant differential diagnosis for episodic vertigo. According to the criteria of the IHS, only 7.8% of these patients would be diagnosed as having basilar migraine. However, to ensure that at least those presenting with monosymptomatic episodic vertigo (78% in our study) receive effective treatment, we propose the use of the more appropriate term "vestibular migraine."

Entities:  

Mesh:

Year:  1999        PMID: 10552234     DOI: 10.1007/s004150050478

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  108 in total

1.  Can vestibular-evoked myogenic potentials help differentiate Ménière disease from vestibular migraine?

Authors:  M Geraldine Zuniga; Kristen L Janky; Michael C Schubert; John P Carey
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-20       Impact factor: 3.497

Review 2.  Vertigo and dizziness in the emergency department.

Authors:  Kevin A Kerber
Journal:  Emerg Med Clin North Am       Date:  2009-02       Impact factor: 2.264

Review 3.  The treatment and natural course of peripheral and central vertigo.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2013-07-22       Impact factor: 5.594

4.  Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms.

Authors:  Robert Gürkov; Claudia Kantner; Michael Strupp; W Flatz; Eike Krause; Birgit Ertl-Wagner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

5.  [Anglicisms necessary in the clinic? The example of vestibular and oculomotor syndromes].

Authors:  D Huppert; T Brandt
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

Review 6.  Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome.

Authors:  Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 7.  Migraine-associated vertigo: diagnosis and treatment.

Authors:  Yoon-Hee Cha
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

8.  Association of benign recurrent vertigo and migraine in 208 patients.

Authors:  Y-H Cha; H Lee; L S Santell; R W Baloh
Journal:  Cephalalgia       Date:  2009-01-16       Impact factor: 6.292

9.  A New Diagnostic Approach to the Adult Patient with Acute Dizziness.

Authors:  Jonathan A Edlow; Kiersten L Gurley; David E Newman-Toker
Journal:  J Emerg Med       Date:  2018-02-01       Impact factor: 1.484

10.  [Neurological and somatoform vertigo syndromes].

Authors:  M Dieterich; A Eckhardt-Henn
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.